Cook KL

No ORCID on file · 2 papers in corpus
2025
JCI insight ·doi:10.1172/jci.insight.182694

Many risk-eligible women refuse tamoxifen for primary prevention of breast cancer due to concerns about common side effects such as vasomotor symptoms. Tamoxifen may also induce or worsen insulin resistance and hypertriglyceridemia, especia…

2022
Endocrinology ·doi:10.1210/endocr/bqac177

Despite advances in treatment strategies, breast cancer (BC) remains one of the most prevalent cancers worldwide. Recent studies implicate the gut microbiome as a potential risk factor for BC development. Alterations in gut microbial divers…